Identification of human endogenous retrovirus transcripts in Hodgkin Lymphoma cells

Mol Biol Rep. 2019 Apr;46(2):1885-1893. doi: 10.1007/s11033-019-04640-x. Epub 2019 Feb 1.

Abstract

During the last decades, the prognosis for patients with Hodgkin Lymphoma (HL) has been steadily improved. Nevertheless, new and less toxic therapy strategies have to be developed especially for patients with advanced disease. The activation of human endogenous retroviruses (HERV) is suspected to occur in HL and therefore, HERV might represent interesting target structures. In order to identify transcribed HERV of the HERV-H and HERV-K families in HL we used a reverse transcription-polymerase chain reaction based cloning approach. In addition to unspliced HERV-H and HERV-K transcripts, we detected spliced HERV-K transcripts that matched genomic sequences with the expected splicing-donor and splicing-acceptor sites. Of particular interest was the expression of HERV-K18 related transcripts at the CD48 locus. Our data indicate transcriptional activity of several HERV loci in HL cells.

Keywords: CD48; Cloning; Endogenous retroviruses; Hodgkin Lymphoma; Splicing.

MeSH terms

  • CD48 Antigen / genetics
  • Cell Line, Tumor
  • Endogenous Retroviruses / classification
  • Endogenous Retroviruses / genetics*
  • Hodgkin Disease / virology*
  • Humans
  • RNA Splicing
  • Transcription, Genetic
  • Transcriptional Activation

Substances

  • CD48 Antigen
  • CD48 protein, human